OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
300755$14.5158

Vats Liquor Chain Store Management Joint Stock Co Ltd

Food Retail & DistributionVerified

The company's capital structure shows a debt-to-equity ratio of 0.31, indicating a relatively conservative leverage position compared to industry norms. The liquidity position is mixed, with a current ratio of 2.21, suggesting the company can cover its short-term obligations, but the negative net cash position after subtracting total debt raises concerns about liquidity flexibility. Profitability metrics are weak, with a return on equity (ROE) of -13.4% and a return on assets (ROA) of -7.67%, both significantly below the industry median. The company reported a net loss of CNY 368.8 million, and operating income was negative at CNY 362.5 million, indicating operational inefficiencies and cost overruns. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic shifts and regulatory changes. The absence of segment-specific data limits the ability to assess the performance of different parts of the business. The company's growth trajectory is uncertain, with no disclosed revenue growth in the most recent period. Analysts have set a mean price target of CNY 23.10, implying a potential upside of 59.2% from the current market price of CNY 14.51. However, the company's negative operating and net income suggest that achieving this growth may be challenging without significant operational improvements. Risk factors include a negative net cash position and the potential for dilution, although the risk of dilution is currently assessed as low. The company has not issued additional shares recently, and there is no indication of imminent dilutive events. However, the negative free cash flow of CNY -413.3 million may necessitate future capital raising, which could lead to dilution. Recent events include the publication of the latest financial results, which show a significant decline in profitability. The company has not disclosed any major strategic initiatives or capital expenditures that could drive future growth. The absence of positive developments in the recent filings and transcripts suggests a lack of momentum in the business.

30-day price · 300755+1.57 (+12.1%)
Low$12.30High$16.20Close$14.51As of15 May, 00:00 UTC
Profile
CompanyVats Liquor Chain Store Management Joint Stock Co Ltd
Ticker300755.SZ
SectorConsumer Non-Cyclicals
BusinessFood & Drug Retailing
Industry groupFood & Drug Retailing
IndustryFood Retail & Distribution
AI analysis

Business. Vats Liquor Chain Store Management Joint Stock Co Ltd operates in the food retail and distribution industry, providing liquor and related products through a chain store model.

Classification. The company is classified under the Consumer Non-Cyclicals economic sector, Food & Drug Retailing business sector, and Food Retail & Distribution industry with a confidence level of 0.92.

The company's capital structure shows a debt-to-equity ratio of 0.31, indicating a relatively conservative leverage position compared to industry norms. The liquidity position is mixed, with a current ratio of 2.21, suggesting the company can cover its short-term obligations, but the negative net cash position after subtracting total debt raises concerns about liquidity flexibility. Profitability metrics are weak, with a return on equity (ROE) of -13.4% and a return on assets (ROA) of -7.67%, both significantly below the industry median. The company reported a net loss of CNY 368.8 million, and operating income was negative at CNY 362.5 million, indicating operational inefficiencies and cost overruns. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic shifts and regulatory changes. The absence of segment-specific data limits the ability to assess the performance of different parts of the business. The company's growth trajectory is uncertain, with no disclosed revenue growth in the most recent period. Analysts have set a mean price target of CNY 23.10, implying a potential upside of 59.2% from the current market price of CNY 14.51. However, the company's negative operating and net income suggest that achieving this growth may be challenging without significant operational improvements. Risk factors include a negative net cash position and the potential for dilution, although the risk of dilution is currently assessed as low. The company has not issued additional shares recently, and there is no indication of imminent dilutive events. However, the negative free cash flow of CNY -413.3 million may necessitate future capital raising, which could lead to dilution. Recent events include the publication of the latest financial results, which show a significant decline in profitability. The company has not disclosed any major strategic initiatives or capital expenditures that could drive future growth. The absence of positive developments in the recent filings and transcripts suggests a lack of momentum in the business.
Key takeaways
  • The company is operating at a loss with a negative return on equity and assets.
  • Liquidity is a concern due to the negative net cash position after debt.
  • Analysts have set a high price target, but the company's current financial performance does not support this optimism.
  • The business lacks geographic and segment diversification, increasing risk exposure.
  • The company's capital structure is relatively conservative, but the negative free cash flow may necessitate future capital raising.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$5.90B
Gross profit$69.4M
Operating income-$362.5M
Net income-$368.8M
R&D
SG&A
D&A
SBC
Operating cash flow$751.7M
CapEx-$1.5M
Free cash flow-$413.3M
Total assets$4.81B
Total liabilities$2.05B
Total equity$2.75B
Cash & equivalents
Long-term debt$860.2M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$5.90B-$362.5M-$368.8M-$413.3M
FY-1$9.46B$87.4M$44.4M-$501.0M
FY-2$10.12B$255.9M$235.3M$156.6M
FY-3$8.71B$420.9M$366.3M$65.3M
FY-4$7.46B$825.8M$675.5M$556.2M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$4.81B$2.75B
FY-1$7.11B$3.16B
FY-2$7.25B$3.80B
FY-3$8.44B$3.64B
FY-4$6.83B$3.41B
PeriodOCFCapExFCFSBC
FY0$751.7M-$1.5M-$413.3M
FY-1$436.3M-$5.8M-$501.0M
FY-2$282.9M-$18.5M$156.6M
FY-3-$329.9M-$178.1M$65.3M
FY-4-$373.5M-$72.3M$556.2M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$2.21B$81.4M$53.0M
FQ-1$731.9M-$101.7M-$170.1M
FQ-2$1.21B-$330.1M-$254.9M
FQ-3$1.10B-$37.3M-$29.2M
FQ-4$2.85B$106.6M$85.4M
FQ-5$1.63B-$111.6M-$123.3M
FQ-6$1.89B$8.5M$12.7M
FQ-7$1.81B$27.2M$25.3M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$4.19B$2.81B$1.32B
FQ-1$4.81B$2.75B
FQ-2$5.07B$2.92B$1.15B
FQ-3$5.62B$3.18B
FQ-4$6.40B$3.24B$1.43B
FQ-5$7.11B$3.16B
FQ-6$6.89B$3.61B$875.0M
FQ-7$6.98B$3.76B
PeriodOCFCapExFCFSBC
FQ0$722.1M-$21.6k
FQ-1$751.7M-$1.5M
FQ-2$555.2M-$1.5M
FQ-3$116.6M-$646.8k
FQ-4$417.9M-$553.8k
FQ-5$436.3M-$5.8M
FQ-6-$392.9M-$4.8M
FQ-7-$60.2M-$4.1M
Valuation
Market price$14.51
Market cap$6.05B
Enterprise value$6.91B
P/E
Reported non-GAAP P/E
EV/Revenue1.2
EV/Op income
EV/OCF9.2
P/B2.2
P/Tangible book2.2
Tangible book$2.75B
Net cash-$860.2M
Current ratio2.2
Debt/Equity0.3
ROA-7.7%
ROE-13.4%
Cash conversion-2.0%
CapEx/Revenue-0.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food & Drug Retailing · cohort 234 companies
Metric300755Activity
Op margin-6.1%2.8% medp25 0.9% · p75 5.9%bottom quartile
Net margin-6.3%1.8% medp25 0.3% · p75 3.6%bottom quartile
Gross margin1.2%24.1% medp25 13.8% · p75 31.4%bottom quartile
CapEx / revenue-0.0%-2.0% medp25 -3.8% · p75 -1.0%top quartile
Debt / equity31.0%56.0% medp25 14.0% · p75 113.8%below median
Observations
IR observations
Mean price target23.10 CNY
Median price target23.10 CNY
High price target23.20 CNY
Low price target23.00 CNY
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count2.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.18 CNY
Last actual EPS-0.90 CNY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-16 01:11 UTC#2f6d2bee
Market quoteclose CNY 14.51 · shares 0.42B diluted
no public URL
2026-05-16 01:11 UTC#0f33d6d7
Source: analysis-pipeline (hybrid)Generated: 2026-05-16 01:12 UTCJob: 0c574cc5